Physiological and medical findings in insomnia: Implications for diagnosis andcare

Sleep Medicine Reviews

Volumn 18, Issue 2, 2014, Pages 111-122

  Bonnet, Michael H ^a   Burton, George G ^a   Arand, Donna L ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Depression; Diabetes; Hyperarousal; Hypertension; Insomnia; Pain; Sleep disorders

Indexed keywords

DEPRESSION; DIABETES; HYPERAROUSAL; HYPERTENSION; INSOMNIA; PAIN; SLEEP DISORDERS;

BRAIN; COMORBIDITY; ELECTROENCEPHALOGRAPHY; HUMANS; RISK FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84894989590     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2013.02.003     Document Type: Review

References (93)

1. American Academy of Sleep Medicine International classification of sleep disorders: diagnostic and coding manual 2005, American Academy of Sleep Medicine, Westchester, IL. 2nd ed.
2. Bonnet M.H., Arand D.L. Hyperarousal and insomnia: state of the science. Sleep Med Rev 2010, 14:9-15.
3. Vgontzas A.N., Liao D., Bixler E.O., Chrousos G.P., Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 2009, 32:491-497.
4. Vgontzas A.N., Liao D., Pejovic S., Calhoun S., Karataraki M., Basta M., et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep 2010 Sep 1, 33:1159-1164.
5. Vgontzas A.N., Liao D., Pejovic S., Calhoun S., Karataraki M., Bixler E.O. Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care 2009, 32:1980-1985.
6. Perlis M.L., Smith M.T., Andrews P.J., Orff H., Giles D.E. Beta/gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls. Sleep 2001, 24:110-117.
7. Cervena K., Dauvilliers Y., Espa F., Touchon J., Matousek M., Billiard M., et al. Effect of cognitive behavioural therapy for insomnia on sleep architecture and sleep EEG power spectra in psychophysiological insomnia. JSleep Res 2004, 13:385-393.
8. Krystal A., Edinger J. Sleep EEG predictors and correlates of the response to cognitive behavioral therapy for insomnia. Sleep 2010, 33:669-677.
9. Vgontzas A.N., Bixler E.O., Lin H., Prolo P., Mastorakos G., Vela-Bueno A., et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. JClin Endocrinol Metab 2001, 86:3787-3794.
10. Rodenbeck A., Huether G., Rüther E., Hajak G. Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci Lett 2002, 324:159-163.
11. Rodenbeck A., Cohrs S., Jordan W., Huether G., Ruther E., Hajak G. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. Psychopharmacol 2003, 170:423-428.
12. Adam K., Oswald I., Shapiro C. Effects of loprazolam and of triazolam on sleep and overnight urinary cortisol. Psychopharmacology (Berl) 1984, 82:389-394.
13. Richardson G., Wang-Weigand S. Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia. Hum Psychopharmacol 2009, 24:103-111.
14. Backhaus J., Junghanns K., Hohagen F. Sleep disturbances are correlated with decreased morning awakening salivary cortisol. Psychoneuroendocrinology 2004, 29:1184-1191.
15. Bonnet M.H., Arand D.L. Heart rate variability in insomniacs and matched normal sleepers. Psychosomatic Med 1998, 60:610-615.
16. Stepanski E., Glinn M., Zorick F., Roehrs T., Roth T. Heart rate changes in chronic insomnia. Stress Med 1994, 10:261-266.
17. Varkevisser M., Van Dongen H.P., Kerkhof G.A. Physiologic indexes in chronic insomnia during a constant routine: evidence for general hyperarousal?. Sleep 2005, 28:1588-1596.
18. Jobert M., Poiseau E., Jähnig P., Gaillard P., Schulz H. ECG activity in the sleep of insomniac patients under the influence of lormetazepam and zopiclone. Neuropsychobiology 1995, 31:204-209.
19. Bonnet M.H., Arand D.L. Situational insomnia: consistency, predictors, and outcomes. Sleep 2003, 26:1029-1036.
20. Fang S.C., Huang C.J., Yang T.T., Tsai P.S. Heart rate variability and daytime functioning in insomniacs and normal sleepers: preliminary results. JPsychosom Res 2008, 65:23-30.
21. Jurysta F., Lanquart J.P., Sputaels V., Dumont M., Migeotte P.F., Leistedt S., et al. The impact of chronic primary insomnia on the heart rate - EEG variability link. Clin Neurophysiol 2009, 120:1054-1060.
22. Yang P., Ho K., Chen H., Chien M. Exercise training improves sleep quality in middle-aged and older adults with sleep problems: a systematic review. JPhysiother 2012, 58:157-163.
23. Tworoger S.S., Yasui Y., Vitiello M.V., Schwartz R.S., Ulrich C.M., Aiello E.J., et al. Effects of a yearlong moderate-intensity exercise and a stretching intervention on sleep quality in postmenopausal women. Sleep 2003, 26:830-836.
24. Wilmore J.H., Costill D.L. Physiology of sport and exercise 2011, Human Kinetics, Champaign. 5th ed.
25. Bonnet M.H., Arand D.L. The use of lorazepam TID for chronic insomnia. Int Clin Psychopharmacolocy 1999, 14:81-90.
26. Bonnet M.H., Arand D.L. The consequences of a week of insomnia II: patients with insomnia. Sleep 1998, 21:359-378.
27. Lanfranchi P.A., Pennestri M., Fradette L., Dumont M., Morin C.M., Montplaisir J. Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep 2009, 32:760-766.
28. Huang Y., Mai W., Cai X., Hu Y., Song Y., Qiu R., et al. The effect of zolpidem on sleep quality, stress status, and nondipping hypertension. Sleep Med 2012, 13:263-268.
29. Eriksson A., Ekbom A., Granath F., Hilding A., Efendic S., Ostenson C.G. Psychological distress and risk of pre-diabetes and type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med 2008, 25:834-842.
30. Knutson K.L., Van Cauter E., Zee P., Liu K., Lauderdale D.S. Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study. Diabetes Care 2011, 34:1171-1176.
31. Keckeis M., Lattova Z., Maurovich-Horvat E., Beitinger P., Birkmann S., Lauer C., et al. Impaired glucose tolerance in sleep disorders. PLoS One 2010, 5:e9444.
32. Garfinkel D., Zorin M., Wainstein J., Matas Z., Laudon M., Zisapel N. Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study. Diabetes Metab Syndr Obes 2011, 4:307-313.
33. Bonnet M.H., Arand D.L. 24-Hour metabolic rate in insomniacs and matched normal sleepers. Sleep 1995, 18:581-588.
34. Bonnet M.H., Arand D.L. Physiological activation in patients with sleep state misperception. Psychosomatic Med 1997, 59:533-540.
35. Nofzinger E.A., Buysse D.J., Germain A., Price J.C., Miewald J.M., Kupfer D.J. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 2004, 161:2126-2128.
36. Nofzinger E.A., Nissen C., Germain A., Moul D., Hall M., Price J.C., et al. Regional cerebral metabolic correlates of WASO during NREM sleep in insomnia. JClin Sleep Med 2006, 2:316-322.
37. Nofzinger E., Buysse D., Moul D., Hall M., Germain A., Julie P. Eszopiclone reverses brain hyperarousal in insomnia: evidence from [18]-FDG PET. Sleep 2008, 31. [abstract: A232].
38. Vgontzas A.N., Zoumakis E., Papanicolaou D.A., Bixler E.O., Prolo P., Lin H.M., et al. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism 2002, 51:887-892.
39. Jain S., Kahlon G., Morehead L., Lieblong B., Stapleton T., Hoeldtke R., et al. The effect of sleep apnea and insomnia on blood levels of leptin, insulin resistance, IP-10, and hydrogen sulfide in type 2 diabetic patients. Metab Syndr Relat Disord 2012, 10:331-336.
40. Chiu Y., Chuang Y., Fang K., Liu S., Chen H., Yang J., et al. Higher systemic inflammation is associated with poorer sleep quality in stable haemodialysis patients. Nephrol Dial Transplant 2009, 24:247-251.
41. Taylor-Gjevre R., Gjevre J.A., Nair B., Skomro R., Lim H.J. Improved sleep efficiency after anti-tumor necrosis factor α therapy in rheumatoid arthritis patients. Ther Adv Musculoskelet Dis 2011, 3:227-233.
42. Savard J., Laroche L., Simard S., Ivers H., Morin C.M. Chronic insomnia and immune functioning. Psychosom Med 2003, 65:211-221.
43. Irwin M., Clark C., Kennedy B., Gillin C.J., Ziegler M. Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain Behav Immun 2003, 17:365-372.
44. Cohen S., Doyle W., Skoner D., Rabin B., Gwaltney J.J. Social ties and susceptibility to the common cold. JAMA 1997, 277:1940-1944.
45. Cohen S., Doyle W., Alper C., Janicki-Deverts D., Turner R. Sleep habits and susceptibility to the common cold. Arch Intern Med 2009, 169:62-67.
46. Patel S., Malhotra A., Gao X., Hu F., Neuman M., Fawzi W.W. Aprospective study of sleep duration and pneumonia risk in women. Sleep 2012, 35:97-101.
47. Prather A., Hall M., Fury J., Ross D., Muldoon M., Cohen S., et al. Sleep and antibody response to hepatitis B vaccination. Sleep 2012, 35:1063-1069.
48. Motivala S., Tomiyama A., Ziegler M., Khandrika S., Irwin M. Nocturnal levels of ghrelin and leptin and sleep in chronic insomnia. Psychoneuroendocrinology 2009, 34:540-545.
49. Schuessler P., Uhr M., Ising M., Schmid D., Weikel J., Steiger A. Nocturnal ghrelin levels - relationship to sleep EEG, the levels of growth hormone, ACTH and cortisol - and gender differences. JSleep Res 2005, 14:329-336.
50. Janson C., Lindberg E., Gislason T., Elmasry A., Boman G. Insomnia in men - a 10-year prospective population based study. Sleep 2001, 24:425-430.
51. Krystal A., Cooper J., Schaefer K., M F., Roth T. Weight changes in patients with primary insomnia following long-term eszopiclone treatment. Sleep 2009, 32. [Abstract Supplement: A280].
52. Winkelman J.W., Buxton O.M., Jensen J.E., Benson K.L., O'Connor S.P., Wang W., et al. Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep 2008, 31:1499-1506.
53. Plante D., Jensen J., Schoerning L., Winkelman J. Reduced gammaaminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?. Neuropsychopharm 2012, 37:1548-1557.
54. Morgan P., Pace-Schott E., Mason G., Forselius E., Fasula M., Valentine G., et al. Cortical GABA levels in primary insomnia. Sleep 2012, 35:807-814.
55. Schwartz S., Anderson W.M., Cole S.R., Cornoni-Huntley J., Hays J.C., Blazer D. Insomnia and heart disease: a review of epidemiologic studies. JPsychosom Res 1999, 47:313-333.
56. Fernandez-Mendoza J., Vgontzas A., Liao D., Shaffer M., Vela-Bueno A., Basta M., et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension 2012, 60:929-935.
57. Skomro R., Ludwig S., Salamon E., Kryger M.H. Sleep complaints and restless legs syndrome in adult type 2 diabetics. Sleep Med 2001, 2:417-422.
58. Nilsson P., Rööst M., Engström G., Hedblad B., Berglund G. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care 2004, 27:2464-2469.
59. Meisinger C., Heier M., Loewel H. MONICA/KORA Augsburg Cohort Study. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 2005, 48:235-241.
60. Jennings J., Muldoon M., Hall M., Buysse D., Manuck S. Self-reported sleepquality is associated with the metabolic syndrome. Sleep 2007, 30:219-223.
61. Suarez E. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 2008, 22:960-968.
62. Baglioni C., Battagliese G., Feige B., Spiegelhalder K., Nissen C., Voderholzer U., et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. JAffect Disord 2011, 135:10-19.
63. Troxel W., Kupfer D., Reynolds C.R., Frank E., Thase M., Miewald J., et al. Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations. JClin Psychiatry 2012, 73:478-485.
64. Fava M., McCall W.V., Krystal A., Wessel T., Rubens R., Caron J., et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006, 59:1052-1060.
65. Riemann D., Participants W. Does effective management of sleep disorders reduce depressive symptoms and the risk of depression?. Drugs 2009, 69(Suppl. 2):43-64.
66. Komada Y., Nomura T., Kusumi M., Nakashima K., Okajima I., Sasai T., et al. Correlations among insomnia symptoms, sleep medication use and depressive symptoms. Psychiatry Clin Neurosci 2011, 65:20-29.
67. Norris E., Karen B., Correll J., Zemanek K., Lerman J., Primelo R., et al. Adouble-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder. JAffect Disord 2012, [Epub ahead of print].
68. Roehrs T., Hyde M., Blaisdell B., Greenwald M., Roth T. Sleep loss and REM sleep loss are hyperalgesic. Sleep 2006, 29(2):145-151.
69. Doufas A., Panagiotou O., Ioannidis J. Concordance of sleep and pain outcomes of diverse interventions: an umbrella review. PLoS One 2012, 7:e40891.
70. Tashjian R.Z., Banerjee R., Bradley M.P., Alford W., Fadale P.D. Zolpidem reduces postoperative pain, fatigue, and narcotic consumption following knee arthroscopy: a prospective randomized placebo-controlled double-blinded study. JKnee Surg 2006, 19:105-111.
71. Walsh J., Muehlbach M., Lauter S., Hilliker N., Schweitzer P. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis. JRheumat 1996, 23:245-252.
72. Spaeth M., Bennett R., Benson B., Wang Y., Lai C., Choy E. Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial. Ann Rheum Dis 2012, 71:935-942.
73. Currie S., Wilson K., Pontefract A., deLaplante L. Cognitive-behavioral treatment of insomnia secondary to chronic pain. JConsult Clin Psychol 2000 Jun, 68(3):407-416.
74. Edinger J.D., Wohlgemuth W.K., Krystal A.D., Rice J.R. Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med 2005, 165:2527-2535.
75. Jungquist C.R., O'Brien C., Matteson-Rusby S., Smith M.T., Pigeon W.R., Xia Y., et al. The efficacy of cognitive-behavioral therapy for insomnia in patients with chronic pain. Sleep Med 2010, 11:302-309.
76. Vitiello M., Rybarczyk B., Von Korff M., Stepanski E. Cognitive behavioral therapy for insomnia improves sleep and decreases pain in older adults with co-morbid insomnia and osteoarthritis. JClin Sleep Med 2009, 5:355-362.
77. Pollak C., Perlick D., Linsner J., Wenston J., Hsieh F. Sleep problems in the community elderly as predictors of death and nursing home placement. JCommunity Health 1990, 15:123-135.
78. Althuis M., Fredman L., Langenberg P., Magaziner J. The relationship between insomnia and mortality among community-dwelling older women. JAm Geriatr Soc 1998, 46:1270-1273.
79. Mallon L., Broman J.E., Hetta J. Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. JIntern Med 2002, 251:207-216.
80. Phillips B., Mannino D. Does insomnia kill?. Sleep 2005, 28:965-971.
81. Chien K., Chen P., Hsu H., Su T., Sung F., Chen M., et al. Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: report from a community-based cohort. Sleep 2010, 33:177-184.
82. Omachi T., Blanc P., Claman D., Chen H., Yelin E., Julian L., et al. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med 2012, 13:476-483.
83. Martin J., Fiorentino L., Jouldjian S., Mitchell M., Josephson K., Alessi C. Poor self-reported sleep quality predicts mortality within one year of inpatient post-acute rehabilitation among older adults. Sleep 2011, 34:1715-1721.
84. Mallon L., Broman J., Hetta J. Is usage of hypnotics associated with mortality?. Sleep Med 2009, 3:279-286.
85. Gangwisch J.E., Heymsfield S.B., Boden-Albala B., Buijs R.M., Kreier F., Opler M.G., et al. Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample. Sleep 2008, 31:1087-1096.
86. Fernandez-Mendoza J., Calhoun S., Bixler E., Karataraki M., Liao D., Vela-Bueno A., et al. Sleep misperception and chronic insomnia in the general population: role of objective sleep duration and psychological profiles. Psychosom Med 2011, 73:88-97.
87. Spiegelhalder K., Fuchs L., Ladwig J., Kyle S.D., Nissen C., Voderholzer U., et al. Heart rate and heart rate variability in subjectively reported insomnia. JSleep Res 2011 Mar, 20:137-145.
88. Krystal A.D., Edinger J.D., Wohlgemuth W.K., March G.R. Non-REM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. Sleep 2002, 25:630-640.
89. Taylor D.J., Mallory L.J., Lichstein K.L., Durrence H.H., Riedel B.W., Bush A.J. Comorbidity of chronic insomnia with medical problems. Sleep 2007, 30:213-218.
90. Cano G., Mochizuki T., Saper C.B. Neural circuitry of stress-induced insomnia in rats. JNeurosci 2008, 28:10167-10184.
91. Riemann D., Spiegelhalder K., Feige B., Voderholzer U., Berger M., Perlis M., et al. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 2010, 14:19-31.
92. Podrid P. Myocardial infarction 2011, UpToDate.
93. Bastien C.H., LeBlanc M., Carrier J., Morin C.M. Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines. Sleep 2003, 26:313-317.